Description
Pioglitazone Tablets
• Product Overview
Pioglitazone Tablets are oral antidiabetic medicines belonging to the Thiazolidinedione (TZD) class. They are used to improve blood glucose control in adults with Type 2 Diabetes Mellitus by increasing the body’s sensitivity to insulin. Pioglitazone helps lower blood sugar levels without stimulating insulin secretion and is commonly prescribed as monotherapy or in combination with other antidiabetic medications, along with diet and exercise.
• Available Strengths
– Pioglitazone 15 mg Tablets
– Pioglitazone 30 mg Tablets
– Pioglitazone 45 mg Tablets
• Therapeutic Category
Oral Antidiabetic (Thiazolidinedione)
• Indications
Pioglitazone Tablets are indicated for the management of:
– Type 2 Diabetes Mellitus
– Blood glucose control in combination with diet and exercise
– Monotherapy (when appropriate)
– Combination therapy with Metformin, Sulfonylureas, DPP-4 inhibitors, SGLT2 inhibitors, or Insulin
• Common Side Effects
Some patients may experience:
– Weight gain
– Swelling of the ankles or feet (Edema)
– Headache
– Upper respiratory tract infection
– Muscle pain
– Sinusitis
• Serious Side Effects
Seek immediate medical attention if any of the following occur:
– Heart failure or worsening heart failure
– Severe allergic reactions (Anaphylaxis)
– Liver dysfunction or jaundice
– Vision changes due to macular edema
– Bone fractures (especially in women)
– Severe hypoglycemia (when used with insulin or sulfonylureas)
• Precautions
– Use only under the supervision of a healthcare professional.
– Monitor blood glucose levels regularly.
– Use cautiously in patients with heart failure, liver disease, or fluid retention.
– Periodic liver function tests may be recommended.
– Not indicated for Type 1 Diabetes Mellitus or diabetic ketoacidosis.
– Consult a healthcare professional before use during pregnancy or breastfeeding.
– Store below 30°C in a cool, dry place away from moisture and direct sunlight.
• Technical Information
• Active Ingredient
Pioglitazone
• Mechanism of Action
Pioglitazone activates PPAR-γ (Peroxisome Proliferator-Activated Receptor Gamma) receptors, improving insulin sensitivity in muscle, fat, and liver tissues, thereby reducing blood glucose levels.
• Dosage Form
Tablet
• Route of Administration
Oral
• Shelf Life
24–36 Months (depending on packaging and regulatory requirements)
• Storage Conditions
Store below 30°C in a dry place protected from moisture and direct sunlight.
• Product Specifications
Product Name:- Pioglitazone Tablets
Generic Name:- Pioglitazone
Strengths:- 15 mg, 30 mg, 45 mg
Dosage Form:- Tablet
Category:- Oral Antidiabetic (Thiazolidinedione)
Packaging:- Blister / Alu-Alu / Customized Export Packing
Shelf Life:- 24–36 Months
Storage:- Below 30°C
Origin:- India
• Regulatory Status & Supply Information
– Manufactured in WHO-GMP compliant facilities.
– Available for international export markets.
– Export documentation support available.
– Private Label Manufacturing available.
– Third-Party Manufacturing available.
– Customized export packaging available.
– Bulk quantities available for distributors, wholesalers, hospitals, pharmacies, and government tenders.
• Who Should Source This Product?
This product is ideal for:
– Pharmaceutical Importers
– Pharmaceutical Distributors
– Medicine Wholesalers
– Hospital Procurement Companies
– Pharmacy Chains
– Diabetes Care Clinics
– Government Procurement Agencies
– Tender Suppliers
– Private Label Brands
• Why Source From Mediora Exports?
– Trusted Pharmaceutical Exporter from India
– Competitive International Pricing
– WHO-GMP Manufacturing Partners
– Wide Product Portfolio
– Reliable Global Supply Chain
– Flexible Packaging Options
– Timely Delivery
– Complete Export Documentation Support
– Dedicated Customer Support
• Contact Details
Mediora Exports
📧 Email: info@medioraexports.com
📱 Phone/WhatsApp: +91 99047 64844
For product inquiries, quotations, distributorship opportunities, private labeling, and bulk export orders, please contact our team.
Reviews
There are no reviews yet.